Mitsuru Claire Chino is the Managing Executive Officer of ITOCHU Corporation, a Fortune 500 company headquartered in Tokyo, Japan. She was previously president and CEO of ITOCHU International, the company’s New York-based North America-focused subsidiary. In 2013, she became the first female executive officer of any major trading company in Japan. Before joining ITOCHU, she practiced as a lawyer at an international law firm in the United States and in Hong Kong at Graham & James. Asia Legal Business recognized her as a “Top 25 In-House Counsel in Asia,” and the Financial Times named her the “Asia Pacific’s Innovative Lawyer” and included her on the “FT Global General Counsel 30” list of the world’s top in-house lawyers. She has also been a Young Global Leader at the World Economic Forum and a Yale University Maurice R. Greenberg World Fellow. She is a classically trained singer and has given solo performances at venues like the Weill Carnegie Hall and the Suntory Hall.
Podcasts
Mitsuru Claire Chino on Law and Business in Asia
- Business, Law
Recent Posts
TAG Partner Dan Kritenbrink Spoke to PBS NewsHour on the Evolution of US-Vietnam Trade 50 Years Since of the End of the Vietnam War
May 1, 2025
Media Mentions
TAG Partner Dan Kritenbrink joined PBS NewsHour’s Nick Schifrin, on the 50th anniversary of the end of the Vietnam War, ...
TAG Managing Partner Amb. Kurt Tong Delivers Keynote Address at the Hankyung 2025 Global Financial Conference
May 1, 2025
Media Mentions
TAG Managing Partner Amb. Kurt Tong delivered a keynote address to 300 business executives, government officials, and other stakeholders at ...
TAG Partner Amb. Dan Kritenbrink Appears on CNN’s Amanpour to Discuss U.S.-Vietnam Relations
April 30, 2025
Media Mentions
This week marks 50 years since the fall of Saigon, which ended two decades of brutal war in Vietnam that ...
TAG Managing Partner Amb. Kurt Tong Attended 2025 US Strategy Roundtable for Pharma and Biotech held at the Korea Chamber of Commerce and Industry
April 29, 2025
Media Mentions
“Korean companies should conduct thorough research to understand the implications of the current landscape, particularly regarding the BioSecure Act and ...